WuXi PharmaTech Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 135.2 | 69.9 | 33.8 |
| Cost of Goods Sold | 72.3 | 35.6 | 15.5 |
| Gross Profit | 62.8 | 34.3 | 18.3 |
| Gross Profit Margin | 46.5% | 49.1% | 54.1% |
| SG&A Expense | 23.7 | 20.3 | 7.5 |
| Depreciation & Amortization | 8.9 | 3.9 | 2.0 |
| Operating Income | 30.2 | 10.1 | 8.7 |
| Operating Margin | 22.3% | 14.5% | 25.9% |
| Nonoperating Income | 6.4 | 0.2 | (0.2) |
| Nonoperating Expenses | 1.2 | 1.1 | 1.3 |
| Income Before Taxes | 35.4 | 9.3 | 7.2 |
| Income Taxes | 1.5 | 0.4 | 1.1 |
| Net Income After Taxes | 33.9 | 8.8 | 6.1 |
| Continuing Operations | 33.9 | 8.9 | 6.1 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 33.9 | 8.9 | 6.1 |
| Total Net Income | 33.9 | 8.9 | 6.1 |
| Net Profit Margin | 25.1% | 12.7% | 18.1% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
